April 5, 2021
Mayo Clinic Research in the news — 4/5/2021
Mayo Clinic research and faculty experts were featured in a variety of news stories including 3D printed surgical models, early treatment for smoldering multiple myeloma, and heart attacks in women. Updated guideline highlights new therapies, considerations in anaplastic thyroid cancer Healio, 4/1/2021 An updated guideline for best practices in managing anaplastic thyroid cancer stresses the […]
Tags: 3D printing, Alfredo Quinones-Hinojosa, Alzheimer's disease, artificial intelligence, blood cancer, chronic kidney disease, Clifford Jack Jr., COVID-19, digital health, Eric Moore, genetic testing, genetics
February 16, 2021
First hybrid gene therapy shows early promise in treating long QT syndrome
In a new study published in Circulation, Mayo Clinic researchers provide the first preclinical, proof-of-concept study for hybrid gene therapy in long QT syndrome, a potentially lethal heart rhythm condition. Researchers demonstrated its potential therapeutic efficacy in two in vitro model systems using beating heart cells reengineered from the blood samples of patients with type 1 long […]
Tags: cardiology, cardiovascular disease, cardiovascular medicine, Center for Individualized Medicine, Center for Regenerative Medicine, gene therapy, long QT syndrome, Michael Ackerman, molecular pharmacology and experimental therapeutics, pediatric cardiology, pediatric research, sudden cardiac death
January 4, 2021
Research News Roundup – Q4 2020
The year 2020 was a time during which medical and many other researchers around the world focused much of their attention and effort on a single topic – the SARS-CoV-2 virus and related COVID-19 viral infection. However, other research continued, findings were published, and evidence built for improvements in health outcomes and delivery of health […]
Tags: antibiotic, artificial intelligence, brain, cancer research, cardiology, cardiovascular medicine, Center for Individualized Medicine, Center for the Science of Health Care Delivery, clinical research, clinical trials, collaboration, coronary artery disease
March 23, 2020
Collaboration brings innovative regenerative therapies to babies with rare heart defect
By Jen Schutz
A collaboration bringing together regional centers and advocacy groups to accelerate innovation and discovery is expanding, bringing clinical trials and expertise to more patients with Hypoplastic Left Heart Syndrome (HLHS) across the country. Led by Mayo Clinic’s Todd and Karen Wanek Family Program for HLHS, the collaboration began in 2017 and now has 10 members. Nine […]
Tags: Center for Regenerative Medicine, clinical trials, congenital heart disease, HLHS, hypoplastic left heart syndrome, pediatric cardiology, Tim Nelson
September 24, 2019
Research for infants with HLHS moves forward
By Jen Schutz
Hypoplastic left heart syndrome (HLHS) is a complex and rare heart defect present at birth in which the left side of a child’s heart is severely underdeveloped. At Mayo Clinic, physicians and researchers in the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome are looking for ways to delay or even prevent heart failure for […]
Tags: Center for Regenerative Medicine, clinical trials, HLHS, hypoplastic left heart syndrome, pediatric cardiology, stem cells
February 2, 2017
A golden age for pediatric cardiology
By Advancing the Science contributor
Mayo Clinic’s Division of Pediatric Cardiology is on a roll, according to Division Chair Frank Cetta, M.D. “In the last two decades, we’ve really burst onto the scene,” he says. “We’re engaged in exciting research not found elsewhere, and we offer the full spectrum of cardiac care — from fetal diagnosis through specialized treatment for […]
Tags: cardiology, clinical trials, David Driscoll, Frank Cetta, heart disease, heart transplant, Jonathan Johnson, Mayo Clinic Children's Center, pediatric cardiology, pediatric transplant, regenerative medicine, Richard Bram